International Prostate Symptom Score (IPSS)/American Urological Association Symptom Index (AUA-SI)
ورودیهای بالینی بیمار
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Mild0–7
- Moderate8–19
- Severe20–35
The International Prostate Symptom Score (IPSS)/American Urological Association Symptom Index (AUA-SI) calculator is designed for bedside evaluating lower urinary tract symptoms, nephrolithiasis burden, and prostate cancer risk in clinical practice. The resulting score directly guides clinician decision-making regarding initiating medical expulsive or alpha-blocker therapy, ordering.
Clinical Guidelines & Evidence
Measures severity of benign prostatic hyperplasia (BPH) symptoms using 7 questions about urinary symptoms to guide treatment decisions.
Clinical Indication
The International Prostate Symptom Score (IPSS)/American Urological Association Symptom Index (AUA-SI) is indicated for bedside clinical practice to support Measures severity of benign prostatic hyperplasia (BPH) symptoms using 7 questions about urinary symptoms to guide treatment decisions.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with renal colic, hematuria, benign prostatic hyperplasia (BPH), or urogenital malignancies. Clinical application is indicated across Urology clinics, shock wave lithotripsy suites, and acute urologic surgical services.
Limitations & Contraindications
Serum PSA levels can be transiently elevated by acute prostatitis, urinary retention, or recent instrumentation.
Clinical Pearls & Action Plan
Obstructive urolithiasis complicated by upper urinary tract infection represents a surgical emergency requiring urgent decompression. Guideline pearl: The score helps guide treatment decisions: mild (0-7) - watchful waiting, moderate (8-19) - medical therapy, severe (20-35) - consider surgery..
IPSS Score = Sum of 7 symptom questions: Incomplete emptying (0-5) + Frequency (0-5) + Intermittency (0-5) + Urgency (0-5) + Weak stream (0-5) + Straining (0-5) + Nocturia (0-5). Total range: 0-35 points.
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| incomplete_emptying | integer | Yes | How often have you had the sensation of not emptying your bladder? |
| frequency | integer | Yes | How often have you had to urinate less than every two hours? |
| intermittency | integer | Yes | How often have you found you stopped and started again several times when you urinated? |
| urgency | integer | Yes | How often have you found it difficult to postpone urination? |
| weak_stream | integer | Yes | How often have you had a weak urinary stream? |
| straining | integer | Yes | How often have you had to strain to start urination? |
| nocturia | integer | Yes | How many times do you typically get up at night to urinate? |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–7 | Mild | Mild BPH symptoms |
| 8–19 | Moderate | Moderate BPH symptoms |
| 20–35 | Severe | Severe BPH symptoms |
Evidence-Based References (EBM)
- Barry MJ, Fowler FJ Jr, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, Cockett AT. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol. 1992 Nov;148(5):1549-57. doi: 10.1016/s0022-5347(17)36966-5.DOI: 10.1016/s0022-5347(17)36966-5
- Cockett AT, Aso Y, Denis L, Khoury S, Barry M, Carlton CE Jr, et al. World Health Organization Consensus Committee recommendations concerning the diagnosis of BPH. Prog Urol. 1991 Nov;1(6):957-72.
- Bosch JL, Hop WC, Kirkels WJ, Schröder FH. The International Prostate Symptom Score in a community-based sample of men between 55 and 74 years of age: prevalence and correlation of symptoms with age, prostate volume, flow rate and residual urine volume. Br J Urol. 1995 Dec;76(6):625-33.